Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:43:28.708Z.
Calculation as of: 2026-10-06T19:43:28.708Z.
Quote observation: 2026-10-06T19:40:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 667dd3b64d3a271f66e92979ae52668ccbc7e2b5b2cdee7c8377401ac3ef4785
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Tectonic Therapeutic, Inc.
Market Cap
$423.92M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$424.40M
Operating Cash Flow Yield
N/A
TTM Avg
0.69%
3Y Avg
0.69%
5Y Avg
0.69%
Market Cap
$422.75M
Operating Cash Flow Yield
N/A
TTM Avg
1.02%
3Y Avg
1.02%
5Y Avg
1.02%
Market Cap
$419.18M
Operating Cash Flow Yield
N/A
TTM Avg
1.96%
3Y Avg
1.96%
5Y Avg
1.96%
Market Cap
$428.08M
Operating Cash Flow Yield
5.15%
TTM Avg
5.09%
3Y Avg
4.22%
5Y Avg
4.07%
Market Cap
$419.61M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$417.78M
Operating Cash Flow Yield
N/A
TTM Avg
4.45%
3Y Avg
4.45%
5Y Avg
4.45%
Market Cap
$412.91M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$435.72M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $423.92M | N/A | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $424.40M | N/A | 0.69% | 0.69% | 0.69% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.75M | N/A | 1.02% | 1.02% | 1.02% |
| Editas Medicine, Inc. (EDIT)vs › | $419.18M | N/A | 1.96% | 1.96% | 1.96% |
| NeoGenomics, Inc. (NEO)vs › | $428.08M | 5.15% | 5.09% | 4.22% | 4.07% |
| Senseonics Holdings, Inc. (SENS)vs › | $419.61M | N/A | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $417.78M | N/A | 4.45% | 4.45% | 4.45% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.91M | N/A | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $435.72M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $409.72M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
